Definium Therapeutics, Inc. · NASDAQ:DFTX
Deep Track Capital, LP's stake in Definium Therapeutics, Inc. fell to 3.01% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Deep Track Capital, LP's stake in Definium Therapeutics, Inc. fell to 3.01%, 3,000,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 3.01%
- Shares
- 3,000,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 3.01% | 3,000,000 |
| Deep Track Biotechnology Master Fund, Ltd. | 3.01% | 3,000,000 |
| David Kroin | 3.01% | 3,000,000 |
Source
Related
- Definium Therapeutics, Inc.
- Deep Track Capital, LP
- Definium Therapeutics, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Feb 13, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 29, 2026